Crossmark

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view

Crossref DOI link: https://doi.org/10.1186/s12876-015-0266-6

Published Online: 2015-03-24

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bencsikova, Beatrix

Bortlicek, Zbynek

Halamkova, Jana

Ostrizkova, Lenka

Kiss, Igor

Melichar, Bohuslav

Pavlik, Tomas

Dusek, Ladislav

Valik, Dalibor

Vyzula, Rostislav

Zdrazilova-Dubska, Lenka
License Information

License valid from 2015-03-24
More Information

Article History

Received: 8 April 2014

Accepted: 11 March 2015

First Online: 24 March 2015